母婴月子产业
Search documents
紫元元(08223.HK)拟携手深圳前海鹏峰实业科技共同探索中药材产业数字化转型及资产价值提升
Ge Long Hui· 2025-12-23 10:22
Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Shenzhen Qianhai Pengfeng Industrial Technology Co., Ltd. to explore opportunities in the digital transformation and asset value enhancement of the traditional Chinese medicine industry [1] Group 1: Strategic Cooperation - The agreement aims to establish a long-term strategic partnership focusing on the digital upgrade and platform operation of the traditional Chinese medicine industry [1] - Key areas of collaboration include digitalization of physical assets, joint market expansion for traditional Chinese medicine and related products, and exploring multi-level capital cooperation including equity investment [1] Group 2: Business Operations and Expertise - The company primarily engages in financing leasing services for medical equipment, maternal and infant care services, and trade of medical devices and consumables in China [1] - The board believes that this strategic cooperation will enhance the company's capabilities in asset management and supply chain services without altering its existing core business [1] - The collaboration is expected to improve asset management efficiency and supply chain transparency in the field of traditional Chinese medicine [1] Group 3: Long-term Value Creation - Through synergy in technology, platforms, and market resources with the partner, the company aims to expand its business landscape in the healthcare and related supply chain service sectors [2] - The board considers the terms of the framework agreement to be fair and reasonable, aligning with the overall interests of the company and its shareholders [2]
紫元元(08223) - 自愿性公告有关订立战略合作框架协议
2025-12-23 10:10
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或 完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 Ziyuanyuan Holdings Group Limited 紫元元控股集團有限公司 (於開曼群島註冊成立的有限公司) (股份代號:8223) 自願性公告 有關訂立戰略合作框架協議 本公告乃由紫元元控股集團有限公司(「本公司」),連同其附屬公司統稱「本集團」)自願刊 發,旨在告知本公司股東及潛在投資者有關本集團最新業務發展。 訂立戰略合作框架協議 本公司董事(「董事」)會(「董事會」)欣然宣佈,於二零二五年十二月二十三日,本公司與 深圳前海鵬峰實業科技有限公司(「鵬峰科技」)訂立戰略合作框架協議(「框架協議」),雙 方同意建立長期戰略合作關係,共同探索中藥材產業數字化轉型及資產價值提升等領域的合作機 遇。 據董事經作出一切合理查詢後所知、所悉及所信,於本公告日期,鵬峰科技及其最終實益擁有人 均為獨立於本公司及其關連人士(定義見香港聯合交易所有限公司證券 GEM 上市規則(「GEM 上 市規則」)) ...